Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(2001): Fife KH+, Sex Transm Dis 28(4), 226
(1999): Perry CM+, Drugs 58(2), 375
Flaking (18–67%)
(2006): Hadley G+, J Invest Dermatol 126(6), 1251 (9%)
(1999): Perry CM+, Drugs 58(2), 375 (67%)
Fungal dermatitis (2–11%)
Hypomelanosis
(2006): Mendonca CO+, Clin Exp Dermatol 31(5), 721
Induration (5%)
Irritation (sic) (16%)
(1998): Beutner KR+, JAmAcadDermatol38(2), 230 (16.7%)
Pemphigus
(2004): Ruocco E+, Eur J Obstet Gynecol Reprod Biol 115(2), 242
(2003): Campagne G+, Eur J Obstet Gynecol Reprod Biol
109(2), 224
Pemphigus foliaceus
(2005): Mashiah J+, Arch Dermatol 141(7), 908
(2004): Lin R+, Arch Dermatol 140(7), 889
Pigmentation
(2005): Brown T+, JAmAcadDermatol52(4), 715
(2000): Geisse JK, Dermatol Surg 26, 579
Pruritus (22–75%)
(2006): Prescrire Int 15(84), 130
(2004): Barton JC, J Am Acad Dermatol 2004 Sep 51(3), 477
(2003): Bayerl C+, Br J Dermatol 149 Suppl 66, 25 (75%)
(2001): Gollnick H+, IntJSTDAIDS12(1), 22
(1999): Perry CM+, Drugs 58(2), 375 (67%)
(1998): Beutner KR+, JAmAcadDermatol38(2), 230 (54.2%)
Psoriasis
(2006): Fanti PA+, Int J Dermatol 45(12), 1464
(2006): Rajan N+, Clin Exp Dermatol 31(1), 140
Scabbing (4%)
Tenderness (local) (12%)
(2002): Schroeder TL+, JAmAcadDermatol46(4), 545
(1998): Beutner KR+, JAmAcadDermatol38(2), 230 (12.5%)
Ulcerations (5–10%)
(2005): Nikkels AF+, Acta Clin Belg 60(5), 227
(2002): Chen TM+, Dermatol Surg 28, 344 (for BCCs) (focal)
(2002): Emmet S, Solana Beach, CA (topical on lips) (from
Internet) (observation)
(2001): Fife KH+, Sex Transm Dis 28(4), 226
(1998): Beutner KR+, JAmAcadDermatol38(2), 230 (10.4%)
Vesiculation (2–3%)
(2001): Fife KH+, Sex Transm Dis 28(4), 226
Mucosal
Aphthous stomatitis
(2005): Chakrabarty AK+, JAmAcadDermatol52(2 Suppl 1), 35
(2004): Emmet S, San Diego, CA (from Internet) (observation)
(2004): Emmet S, Solana Beach, CA (3 cases) (from Internet)
(observation)
(2004): Panagotacos P, San Francisco, CA (from Internet)
(observation)
(2002): Goldblum O, Pittsburgh, PA (topical on face and lips)
(from Internet) (observation)
(2002): Kaufmann MD, New York, NY (topical on face) (from
Internet) (observation)
Stomatitis
(2005): Chakrabarty AK+, JAmAcadDermatol52(2 Suppl 1), 35
Tongue edema
(2004): Barton JC, J Am Acad Dermatol 2004 Sep 51(3), 477
Hair
Hair – pigmentation (of white hair)
(2002): Kirschenbaum MB, Chicago, IL (from Internet)
(observation)
Eyes
Ocular pigmentation
IMMUNE GLOBULIN I.V. 289
(2004): Emmet S, Solana Beach, CA (from Internet)
(observation)
Other
Application-site reactions (sic)
(2001): Barba AR+, Dermatol Online J 7(1), 20
(2001): Gollnick H+, IntJSTDAIDS12, 22
(2000): Kagy MK+, Dermatol Surg 26(6), 577 (for BCCs)
Cough
(2004): Emmet S, Solana Beach, CA (from Internet)
(observation)
Injection-site Varicella-like eruption
(2006): Holcomb K+, JDrugsDermatol5(9), 863
Myalgia/Myositis/Myopathy/Myotoxicity (1%)
(2002): Sorkin MJ, Denver, CO (topical) (from Internet)
(observation)
Pain (2–11%)
(2006): Prescrire Int 15(84), 130
(2003): Bayerl C+, Br J Dermatol 149 Suppl 66, 25 (11%)
(2001): Gollnick H+, IntJSTDAIDS12(1), 22
(1998): Beutner KR+, JAmAcadDermatol38(2), 230
IMMUNE GLOBULIN I.V.
Synonyms: IGIV; IVIG
Trade names: Allerglobuline; Baygam; Beriglobulin; Citax;
Endobulin; Gamafine; Gamastan; Gamimune (Bayer); Gamma 16;
Gammabulin; Gammagard (Baxter); Gammar P.I.V (ZLB Behring);
Gammer-IV; Gammonayiv; Gamunex (Bayer); IG Gamma; IGIM;
Interglobin; IV Globulin-S; Iveegam (Baxter); Octagam;
Panglobulin (American Red Cross); Pentaglobin; Polygam S/D
(American Red Cross); Sandoglobulin; Sandoglobulina;
Sandoglobuline; Venoglobulin (Alpha Therapeutics)
Category: Immunomodulator
Half-life: N/A
Clinically important, potentially hazardous interactions
with: live vaccines
Reactions
Skin
Baboon syndrome
(1999): Barbaud A+, Dermatology 199(3), 258
Cyanosis
Diaphoresis
Dyshidrosis
(2003): Uyttendaele H+, J Drugs Dermatol 2(3), 337
Eczema
(2003): Eastern J, N Caldwell, NJ (generalized) (from Internet)
(observation)
Lichenoid eruption
(1998): Smith KJ+, J Cutan Med Surg 3(2), 96
Lymphocytic vasculitis
(2006): Bodemer AA+, JAmAcadDermatolA(5), S112
Pallor
Pompholyx
(1999): Iannaccone S+, Neurology 53(5), 1154
Rash (sic)
(2003): Wittstock M+, Eur Neurol 50(3), 172
Toxic epidermal necrolysis
(2006): Trent J+, Seminars Cutan Med Surg 25(2), 91
Urticaria
Vasculitis
(2001): Odum J+, NephrolDialTransplant16(2), 403
(1998): Howse M+, BMJ 317(7168), 1291